- Stocks
- Healthcare
- NASDAQ: CDXS

Price (delayed)

$4.65

Market cap

$326.91M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.12

Enterprise value

$276.24M

The debt has plunged by 63% YoY and by 20% from the previous quarter

CDXS's gross margin is up by 13% year-on-year and by 9% since the previous quarter

The company's net income has shrunk by 127% YoY but it rose by 7% QoQ

The EPS has dropped by 120% year-on-year but it is up by 7% since the previous quarter

CDXS's revenue is down by 49% year-on-year and by 5% since the previous quarter

The equity has declined by 40% year-on-year and by 5% since the previous quarter

What are the main financial stats of CDXS

Market
Valuations
Earnings

Shares outstanding

70.3M

Market cap

$326.91M

Enterprise value

$276.24M

Price to earnings (P/E)

N/A

Price to book (P/B)

3.75

Price to sales (P/S)

4.52

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.94

Revenue

$70.14M

EBIT

-$76.17M

EBITDA

-$66.25M

Free cash flow

-$56.31M

Per share
Balance sheet
Liquidity

EPS

-$1.12

Free cash flow per share

-$0.83

Book value per share

$1.24

Revenue per share

$1.03

TBVPS

$1.97

Total assets

$136.56M

Total liabilities

$49.95M

Debt

$16.02M

Equity

$86.62M

Working capital

$57.64M

Debt to equity

0.19

Current ratio

2.61

Quick ratio

2.39

Net debt/EBITDA

0.76

Margins
Efficiency
Dividend

EBITDA margin

-94.4%

Gross margin

81.7%

Net margin

-108.7%

Operating margin

-97%

Return on assets

-42.6%

Return on equity

-71.2%

Return on invested capital

-91.5%

Return on capital employed

-75.6%

Return on sales

-108.6%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Codexis stock price performed over time

Intraday

25%

1 week

62.02%

1 month

63.16%

1 year

-3.83%

YTD

52.46%

QTD

52.46%

How have Codexis's revenue and profit performed over time

Revenue

$70.14M

Gross profit

$57.33M

Operating income

-$68.07M

Net income

-$76.24M

Gross margin

81.7%

Net margin

-108.7%

The company's net income has shrunk by 127% YoY but it rose by 7% QoQ

The company's operating income has shrunk by 95% YoY but it rose by 17% QoQ

CDXS's revenue is down by 49% year-on-year and by 5% since the previous quarter

Codexis's gross profit has decreased by 43% YoY but it has increased by 3.2% QoQ

What is Codexis's growth rate over time

What is Codexis stock price valuation

P/E

N/A

P/B

3.75

P/S

4.52

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.94

The EPS has dropped by 120% year-on-year but it is up by 7% since the previous quarter

CDXS's price to book (P/B) is 97% higher than its last 4 quarters average of 1.9 but 47% lower than its 5-year quarterly average of 7.1

The equity has declined by 40% year-on-year and by 5% since the previous quarter

The price to sales (P/S) is 97% higher than the last 4 quarters average of 2.3 but 57% lower than the 5-year quarterly average of 10.5

CDXS's revenue is down by 49% year-on-year and by 5% since the previous quarter

How efficient is Codexis business performance

The company's return on invested capital fell by 16% QoQ

Codexis's return on assets has decreased by 8% QoQ

Codexis's return on equity has decreased by 6% QoQ

What is CDXS's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for CDXS.

How did Codexis financials performed over time

CDXS's total assets is 173% greater than its total liabilities

The total liabilities has dropped by 53% year-on-year and by 21% since the previous quarter

CDXS's total assets is down by 45% year-on-year and by 12% since the previous quarter

The debt is 81% less than the equity

The debt has plunged by 63% YoY and by 20% from the previous quarter

The equity has declined by 40% year-on-year and by 5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.